Successful endovascular management of multiple mycotic aneurysms after liver transplantation – A case report and review of the literature

Vascular ◽  
2019 ◽  
Vol 28 (2) ◽  
pp. 165-171
Author(s):  
Jun Jie Ng ◽  
Jarrod Kah Hwee Tan ◽  
Julian Chi Leung Wong ◽  
Bernard Boon Kee Wee ◽  
Iyer Ganpathi Shridhar ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Case Report ◽  
Incidental Finding ◽  
Vascular Complications ◽  
Haemorrhagic Shock ◽  
Liver Graft ◽  
Endovascular Management ◽  
Review Of The Literature ◽  
Mycotic Aneurysms ◽  
Endovascular Approach

Background Mycotic vascular complications after liver transplantation are rare but can be pose a serious threat to the liver graft and the patient’s life. Mycotic complications can present as an incidental finding on routine imaging, or as haemorrhagic shock. Traditionally, these mycotic vascular complications were managed with open surgery. Method/results In this case report, we describe a patient who had developed multiple sequential mycotic aneurysms after liver transplantation which were managed successfully using endovascular and percutaneous techniques. Conclusion An endovascular approach is minimally invasive and will be the way forward in managing these mycotic vascular complications.

scholarly journals Primitive Anorectal Malignant Melanoma: A Rare And Aggressive Localization A Case Report

2020 ◽  
Vol 7 (07) ◽  
pp. 4871-4874
Author(s):  
Amal Hajri ◽  
Abdessamad El Azhary ◽  
Driss Erguibi ◽  
Rachid Boufettal ◽  
Saad Rifki El Jai ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Case Report ◽  
Malignant Melanoma ◽  
Rare Condition ◽  
University Hospital ◽  
Anorectal Melanoma ◽  
Review Of The Literature ◽  
The Third ◽  
Anorectal Malignant Melanoma ◽  
Digestive Cancers

Primary anorectal malignant melanoma is an extremely rare condition. It appears at the third highest frequency after melanomas of the skin and retina. Its prognosis is dreadful because of the early onset of metastases. The treatment remains essentially surgical. We report an observation of primitive anorectal melanoma, collected at the department of surgery for digestive cancers and liver transplantation of the Ibn Rochd University Hospital of Casablanca, with a review of the literature. In order to analyse the clinical, paraclinical and therapeutic characteristics of primary anorectal melanoma.

scholarly journals A POSSIBLE COMPLICATION AFTER LIVER TRANSPLANTATION IN A GASTRIC BYPASS BARIATRIC PATIENT: DON’T FORGET THE EXCLUDED STOMACH! CASE REPORT AND REVIEW OF THE LITERATURE

2020 ◽  
Vol 33 (2) ◽  
Author(s):  
Pietro PERDUCA ◽  
Daniel Reis WAISBERG ◽  
Rafael Soares Nunes PINHEIRO ◽  
Eduardo Guimarães HOURNEAUX-DE-MOURA ◽  
Luiz Augusto Carneiro D’ALBUQUERQUE ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Gastric Bypass ◽  
Case Report ◽  
Review Of The Literature ◽  
Bariatric Patient ◽  
Excluded Stomach

De novo Crohn disease after liver transplantation: Case Report and Review of the literature

2021 ◽  
Author(s):  
J Sollors ◽  
B Kallinowski ◽  
T Gaiser ◽  
C Antoni ◽  
M Ebert ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Case Report ◽  
Crohn Disease ◽  
De Novo ◽  
Review Of The Literature

Acquired Pelger-Huët Anomaly in Association With Concomitant Tacrolimus and Mycophenolate Mofetil in a Liver Transplant Patient: A Case Report and Review of the Literature

2006 ◽  
Vol 130 (1) ◽  
pp. 93-96
Author(s):  
Joan E. Etzell ◽  
Endi Wang
Keyword(s):  
Liver Transplantation ◽  
Mycophenolate Mofetil ◽  
Case Report ◽  
Transplant Patient ◽  
Immunosuppressive Agents ◽  
Single Agent ◽  
Review Of The Literature ◽  
Liver Transplant Patient ◽  
Underlying Causes ◽  
Nuclear Segmentation

Abstract Pelger-Huët anomaly is a congenital or acquired abnormality of neutrophil nuclear segmentation. The acquired form may be a result of a clonal myeloid malignancy, such as myelodysplastic syndrome, or may be a secondary nonclonal change related to a variety of underlying causes, including infections and medications. We report a case of a 56-year-old man who developed acquired Pelger-Huët anomaly following liver transplantation while on the immunosuppressive agents tacrolimus and mycophenolate mofetil. These medications have been reported in association with this abnormality, but usually as a single agent or in combination with other drugs. In our case, the Pelger-Huët anomaly may be the result of the combination of these 2 drugs or mycophenolate alone with subsequent desensitization because resolution of the abnormality occurred after a reduction in mycophenolate mofetil dose, and the abnormality did not recur when mycophenolate mofetil was increased to a dose previously associated with Pelger-Huët anomaly during the time that tacrolimus was discontinued.

Abstract 016: Endovascular Management of Major Vascular Access Site Complications During Transcatheter Aortic Valve Implantation (TAVI).

2017 ◽  
Vol 10 (suppl_3) ◽  
Author(s):  
Muhammad U Majeed ◽  
Kelly D Green ◽  
Marat Fudim ◽  
Mark A Robbins ◽  
David X Zhao
Keyword(s):  
Vascular Access ◽  
Vascular Complications ◽  
Covered Stents ◽  
Endovascular Management ◽  
Access Site ◽  
Femoral Access ◽  
Access Site Complication ◽  
Small Series ◽  
Significant Difference ◽  
Endovascular Approach

Background: Major vascular access site complications remain a challenge in the field of TAVI and are associated with higher 30 day mortality. However, outcomes following endovascular management with covered stents for such complications are not well established. Methods: We reviewed the one year data of patients who underwent TAVI at our institution with a Sapien valve by percutaneous femoral approach. Identified were patients who suffered major vascular complications according to the definitions set forth by the Valve Academic Research Consortium. We then compared the outcome of patients managed by an endovascular approach with a population whose femoral access site complications were managed surgically/endovascularly (85.7% surgically), as reported from the Partner trial. Results: A total of 16 patients experienced Major Vascular complications. TAVI was aborted on 2 patients due to access site complication. Excluded were 3 patients who had benign small ascending aortic dissections after successful valve deployment and 3 patients who were managed surgically. Ten remaining patients were managed by a pure endovascular approach with covered stents. Four of these patients suffered ilio-femoral dissection, 4 had perforation and 2 had both perforation and dissection. No significant difference was observed in pre and post procedure creatinine (1.01 vs 1.14, p=0.16) and none required dialysis within 30 days, as compared with 8.1% in Partner trial. We observed no statistically significant difference between the Partner trial cohort and our patients in 30 day all cause mortality (14.1% vs 10%, p=1), stroke rate (4.8% vs 0%, p=1), access site hematoma (22.9% vs 0%, p=0.1), retroperitoneal bleed (9.5% vs 0%, p=0.6), pseudoaneurysm (3.4% vs 0%, p=1), and gastrointestinal ischemia (1.6% vs 0%). No access site infection, stent thrombosis, or stenosis leading to limb ischemia were noted clinically at 30 day follow-up. Conclusion: Many patients with major vascular complications during TAVI can be treated with a pure endovascular approach. In our small series we observed no difference in concurrent complications when an endovascular repair can be rapidly initiated as compared to a primary surgical approach.

Sign in / Sign up

Export Citation Format

Share Document